Table 2.
Univariate |
Multivariate |
|||||
---|---|---|---|---|---|---|
HR | 95% CI | p Value | HR | 95% CI | p Value | |
Age | 1.333 | (0.714,2.003) | 0.671 | — | — | — |
Gender (female versus male) | 1.672 | (0.847,2.392) | 0.971 | — | — | — |
BMI (kg/m2) | 1.005 | (0.993,1.017) | 0.407 | — | — | — |
Diabetes(yes versus no) | 1.882 | (0.914, 2.727) | 0.884 | — | — | — |
Cardiovascular/cerebrovascular disease (yes versus no) | 1.562 | (0.671, 2.344) | 0.781 | — | — | — |
Systolic blood pressure (mmHg) | 1.032 | (0.921,1.098) | 0.098 | — | — | — |
Diastolic blood pressure (mmHg) | 1.065 | (0.871,1.077) | 0.123 | — | — | — |
RAS inhibitor | 1.073 | (0.422,2.728) | 0.883 | — | — | — |
Diuretics | 0.821 | (0.513,1.313) | 0.410 | — | — | — |
Urate-lowering drugs use | 0.448 | (0.163,1.237) | 0.448 | — | — | — |
Weekly Kt/V urea | 0.240 | (0.127,0.456) | <0.001 | 0.331 | (0.164,0.670) | <0.01 |
peritonitis (yes versus no) | 1.012 | (1.001,1.033) | <0.001 | 1.010 | (1.001,1.018) | <0.001 |
Uric acid (mg/dL) | 1.021 | (1.010,1.032) | <0.01 | 1.033 | (1.001,1.052) | <0.01 |
Bicarbonate (mEq/L) | 1.006 | (1.001,1.113) | <0.05 | 1.212 | (0.914,1.716) | 0.923 |
Phosphorus (mg/dL) | 1.052 | (1.006,1.100) | <0.05 | 1.076 | (0.877,1.318) | 0.267 |
Calcium (mg/dL) | 0.820 | (0.615,1.094) | 0.178 | — | — | — |
BUN (mmol/L) | 1.001 | (0.811,1.003) | 0.333 | — | — | — |
Creatinine (mg/dL) | 1.002 | (0.657,1.560) | 0.658 | — | — | — |
Total cholesterol (mmol/L) | 1.007 | (1.000,1.014) | 0.066 | — | — | — |
LDL-C (mg/dL) | 1.222 | (0.631,1.844) | 0.937 | — | — | — |
Hemoglobin (g/dL) | 0.978 | (0.998,1.001) | 0.595 | — | — | — |
CRP (mg/dl) | 1.453 | (0.775,1.138) | 0.683 | — | — | — |
All continuous variables were follow-up values. BMI: body mass index; BUN: blood urea nitrogen; CRP: C-reactive protein; Kt/V: urea clearance index; LDL-C: low-density lipoprotein cholesterol; RAS inhibitor: Renin-angiotensin system inhibitor.